ArticleEBioMedicine2016

Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.

Rikke B Holmgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.